On ECHEMI
Home > Drugs > Zhengzhou Ruilong Pharmaceutical Co., Ltd.
Zhengzhou Ruilong Pharmaceutical Co., Ltd.
  • Founded in:

    1997-01-28
  • Country:

    China China
  • Address:

    Beimang Industrial Park, Xingyang City
  • Tax NO.:

    91410100614751247U
  • Registered Funds:

    63.1098 million yuan
  • Website:

  • Email:

Related Drugs
Compound Danshen Tablets
Danshen, Panax notoginseng, Borneol
Name Description Content CAS NO. Registered Holders
Salvia Root P.E Tanshinone IIA 20%

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids.

More

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, reduce blood viscosity, and lower blood lipids.

0
NOTOGINSENG RADIX ET RHIZOMA

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

More

It can dilate coronary arteries, increase coronary blood flow, and improve myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reactions, reduce blood viscosity, and reduce blood lipids.

0
Borneol

Compound Danshen Tablets have the effects of dilating coronary arteries, increasing coronary blood flow, slowing heart rate, and improving myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

More

Compound Danshen Tablets have the effects of dilating coronary arteries, increasing coronary blood flow, slowing heart rate, and improving myocardial hypoxia; it can improve acute cardiovascular and cerebrovascular symptoms and ischemic changes in the electrocardiogram; it can inhibit platelet aggregation, inhibit platelet release reaction, reduce blood viscosity, and lower blood lipids.

507-70-0 1
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.